⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890992 | 1.00 | — | — | |
| SCHEMBL17017292 | 1.00 | — | — | |
| SCHEMBL18327197 | 1.00 | — | — | |
| SCHEMBL1445577 | 0.81 | — | — | |
| SCHEMBL28367279 | 0.79 | — | — | |
| SCHEMBL1059901 | 0.76 | — | — | |
| SCHEMBL149026 | 0.74 | — | — | |
| SCHEMBL891118 | 0.73 | — | — | |
| SCHEMBL2302733 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL11620402 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160130349-A1 | MODIFIED ANTIBODIES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | Magenta Therapeutics, Inc. | 2016-05-12 | — | — | US | disclosed |
| US-20150231240-A1 | ANTI-C16ORF54 ANTIBODIES AND METHODS OF USE THEREOF | IGENICA BIOTHERAPEUTICS, INC. (US) | 2015-08-20 | — | — | US | disclosed |